Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom
12:50pm, Thursday, 27'th Feb 2025
FMS, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and su
MASI Stock Gains Following Q4 Earnings Beat, Gross Margin Contracts
12:05pm, Wednesday, 26'th Feb 2025
Masimo's fourth-quarter 2024 results continue to benefit from the strength in its Healthcare and Non-healthcare businesses.
Masimo (MASI) Reports Q4 Earnings: What Key Metrics Have to Say
07:01pm, Tuesday, 25'th Feb 2025
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stree
Masimo (MASI) Tops Q4 Earnings and Revenue Estimates
06:40pm, Tuesday, 25'th Feb 2025
Masimo (MASI) came out with quarterly earnings of $1.80 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $1.25 per share a year ago.
Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript
06:02pm, Tuesday, 25'th Feb 2025
Masimo Corporation (NASDAQ:MASI ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Eli Kammerman - Vice President, Business Development & Investor Relations Katie Szy
Masimo Tops EPS, Revenue Expectations
05:24pm, Tuesday, 25'th Feb 2025
Masimo (MASI -0.69%), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong performanc
Unlocking Q4 Potential of Masimo (MASI): Exploring Wall Street Estimates for Key Metrics
10:20am, Thursday, 20'th Feb 2025
Besides Wall Street's top -and-bottom-line estimates for Masimo (MASI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Can Masimo (MASI) Keep the Earnings Surprise Streak Alive?
01:16pm, Tuesday, 28'th Jan 2025
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Masimo (MASI) is a Great Momentum Stock to Buy
01:00pm, Wednesday, 22'nd Jan 2025
Does Masimo (MASI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Masimo Taps Katie Szyman as Permanent CEO
05:22pm, Tuesday, 21'st Jan 2025
Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.
Masimo names Becton Dickinson's Katie Szyman CEO
04:56pm, Tuesday, 21'st Jan 2025
Masimo said on Tuesday it has named Becton Dickinson executive Katie Szyman as chief executive officer after a bitter proxy battle with activist hedge fund Politan Capital Management led to the ouster
Masimo Announces Leadership Transition
04:00pm, Tuesday, 21'st Jan 2025
IRVINE, Calif.--(BUSINESS WIRE)--Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Ch
Masimo Stock Gains Following Solid Preliminary Q4 Revenues
12:11pm, Monday, 20'th Jan 2025
MASI's revenue growth in the fourth quarter is likely to have been boosted by the continued robust adoption of its products.
Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway
08:30am, Monday, 13'th Jan 2025
UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a sec
Masimo To Rally More Than 13%? Here Are 5 Top Analyst Forecasts For Friday
09:03am, Friday, 27'th Dec 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
